Accelmed Partners has announced it has invested $35 million in SKNV.
SKNV, based in Pompano Beach, Fla., develops medications and skincare solutions for dermatology practices. Founded in 2016 and formerly Sincerus Pharmaceuticals and Prescriber’s Choice, SKNV states it produces medicines for the 12 most common dermatological diagnoses.
Accelmed, based in Aventura, Fla., is a
